Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › MA › BROCKTON › U S LAB & RADIOLOGY LLC

U S LAB & RADIOLOGY LLC

NPI: 1659322360 · BROCKTON, MA 02301 · Clinical Medical Laboratory · NPI assigned 05/15/2006

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official CUOMO, BRIAN controls 20+ related entities in our dataset. Read more

$6.73M
Total Medicaid Paid
3,480,737
Total Claims
2,330,923
Beneficiaries
168
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialCUOMO, BRIAN (AUTHORIZED OFFICIAL/CFO)
NPI Enumeration Date05/15/2006

Related Entities

Other providers sharing the same authorized official: CUOMO, BRIAN

ProviderCityStateTotal Paid
SYMPHONY DIAGNOSTIC SERVICES NO 1 LLC SPARKS MD $38.32M
KAN-DI-KI LLC NORTH HOLLYWOOD CA $13.48M
NEW SCHRYVER LLC DENVER CO $7.16M
KAN-DI-KI LLC LAS VEGAS NV $3.60M
SYMPHONY DIAGNOSTIC SERVICES NO 1 LLC CLEARWATER FL $3.22M
COMMUNITY MOBILE DIAGNOSTICS LLC SAN LEANDRO CA $3.15M
NEW SCHRYVER LLC DENVER CO $3.13M
AMERICAN DIAGNOSTICS SERVICES LLC WINDSOR MILL MD $3.13M
KAN-DI-KI, LLC NORTH HOLLYWOOD CA $784K
KAN-DI-KI LLC TUKWILA WA $623K
NEW SCHRYVER LLC CARROLLTON TX $370K
KAN-DI-KI LLC DENVER CO $289K
KAN-DI-KI LLC NORTH HOLLYWOOD CA $274K
KAN-DI-KI, LLC PORTLAND OR $268K
KAN-DI-KI, LLC LAS VEGAS NV $259K
REONO BERTAGNOLLI A MEDICAL GROUP SAN LEANDRO CA $216K
KAN-DI-KI, LLC PHOENIX AZ $144K
KAN DI KI, LLC CARROLLTON TX $92K
NEW SCHRYVER LLC TUKWILA WA $83K
COMMUNITY MOBILE ULTRASOUND, LLC OCEANSIDE CA $73K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 714,161 $1.32M
2019 679,932 $1.25M
2020 533,313 $1.16M
2021 466,854 $916K
2022 415,982 $789K
2023 378,036 $729K
2024 292,459 $558K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
P9604 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge 414,417 225,876 $1.18M
85025 Blood count; complete (CBC), automated, and automated differential WBC count 301,955 203,754 $707K
80048 Basic metabolic panel (calcium, ionized) 228,803 152,745 $358K
80053 Comprehensive metabolic panel 170,209 136,399 $331K
84443 Thyroid stimulating hormone (TSH) 72,912 68,051 $307K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 26,100 24,909 $222K
83036 Hemoglobin; glycosylated (A1C) 78,826 74,463 $216K
ATP14 79,809 65,786 $185K
ATP08 127,677 88,472 $180K
36415 Collection of venous blood by venipuncture 237,573 122,924 $179K
85027 82,188 68,178 $145K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 5,366 3,176 $143K
83880 17,717 12,509 $139K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 3,552 2,956 $130K
85610 147,016 37,540 $130K
82607 27,563 26,206 $118K
87088 65,299 49,899 $117K
86141 17,191 10,123 $114K
87086 Culture, bacterial; quantitative colony count, urine 61,068 55,094 $110K
80061 Lipid panel 55,973 53,299 $107K
80164 25,808 22,768 $98K
80202 10,367 2,784 $95K
G0471 Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) 436,745 221,623 $93K
87631 1,882 1,806 $75K
82746 15,289 14,590 $69K
83735 24,309 20,019 $53K
84439 18,750 17,665 $50K
82140 6,855 4,959 $48K
80050 General health panel 5,345 5,137 $47K
81001 62,539 56,283 $44K
82728 10,145 9,400 $43K
87186 23,970 20,955 $42K
84134 8,463 7,853 $38K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1,932 1,321 $38K
ATP15 12,654 11,153 $36K
P9603 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled 268,964 160,785 $33K
80177 7,200 6,522 $30K
83970 2,424 2,258 $30K
80185 7,600 4,754 $29K
80076 17,166 15,127 $28K
ATP17 12,415 12,195 $27K
85652 17,450 10,704 $25K
87493 3,711 3,494 $25K
83540 12,917 11,950 $25K
87536 362 339 $23K
87077 13,559 11,673 $23K
84153 2,727 2,573 $18K
82248 18,429 16,042 $18K
83550 7,671 7,193 $18K
87040 3,652 2,239 $16K
ATP07 7,408 6,797 $13K
84436 5,132 4,884 $12K
84146 738 702 $12K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 565 533 $11K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 130 129 $10K
85007 9,254 7,774 $10K
87071 3,353 3,047 $10K
ATP18 4,087 4,016 $9K
80178 4,158 3,431 $9K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 2,416 1,470 $9K
80156 2,504 2,193 $9K
ATP03 7,905 7,709 $9K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 971 899 $9K
84480 1,605 1,505 $8K
ATP09 4,208 3,695 $8K
85004 7,495 3,877 $8K
80162 2,746 2,388 $8K
80184 2,005 1,717 $8K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 393 281 $7K
84132 6,117 4,439 $7K
83690 3,007 2,751 $7K
84100 8,051 6,432 $7K
84479 2,863 2,729 $7K
80159 748 521 $6K
80175 1,684 1,534 $6K
84550 7,566 6,798 $6K
87184 3,284 2,930 $6K
82150 2,629 2,422 $5K
85018 10,225 6,251 $5K
87205 3,722 3,287 $5K
ATP11 3,660 3,584 $5K
85014 9,443 5,679 $5K
ATP10 3,254 3,090 $5K
84466 1,243 1,189 $5K
82565 6,337 4,991 $4K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 391 288 $4K
84520 5,225 4,035 $4K
85048 8,260 4,416 $4K
82550 2,702 2,141 $4K
80074 118 117 $4K
80051 3,022 2,501 $3K
ATP16 942 838 $3K
87899 1,030 464 $3K
82040 4,089 3,892 $3K
87522 Neg quan hep c or qual rna 120 113 $3K
84145 495 429 $3K
87521 Neg quan hep c or qual rna 177 157 $3K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 35 32 $3K
84295 2,679 2,294 $3K
82570 1,730 1,626 $3K
86769 151 107 $3K
83721 1,658 1,558 $3K
85379 829 669 $3K
84481 555 530 $2K
85730 881 827 $2K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 136 135 $2K
86360 55 51 $2K
84460 2,205 1,883 $2K
87070 903 895 $2K
82043 1,108 1,074 $2K
84425 193 184 $2K
85045 1,392 1,282 $2K
80069 763 657 $1K
86803 210 202 $1K
ATP02 1,282 1,189 $1K
87045 484 465 $1K
86592 641 589 $1K
84450 1,948 1,671 $1K
82310 1,059 900 $1K
82947 3,046 2,689 $1K
82553 133 95 $925.11
87081 600 388 $766.26
84484 244 218 $698.35
86361 32 29 $684.54
86355 55 51 $682.00
86359 55 51 $682.00
87015 460 416 $648.81
83615 773 645 $637.22
85049 355 242 $549.13
80183 79 73 $539.23
ATP19 187 179 $456.40
86038 100 94 $453.22
84155 1,188 1,138 $438.63
87300 43 43 $413.35
82105 41 41 $366.76
ATP04 301 281 $345.34
82784 68 44 $338.09
87147 224 171 $336.59
84075 384 301 $306.00
82977 338 284 $302.80
88112 16 12 $273.06
G2024 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source 83 74 $244.54
87328 52 50 $204.49
87329 51 49 $204.19
84156 183 162 $188.17
80186 63 48 $174.83
87340 24 24 $165.34
ATP13 124 121 $163.35
82330 31 25 $140.68
87177 59 58 $134.47
80197 39 26 $130.43
ATP12 42 42 $130.20
86706 13 13 $120.38
86618 12 12 $119.31
82533 13 12 $96.03
87807 51 51 $85.38
87449 21 16 $59.51
83921 30 27 $46.88
ATP06 15 14 $32.32
87299 22 21 $28.04
87279 21 20 $21.95
87276 21 20 $21.45
87260 21 20 $19.56
87280 21 20 $18.94
87275 21 20 $18.25
G0103 Prostate cancer screening; prostate specific antigen test (psa) 63 61 $16.05
84165 13 12 $12.87
82272 18 12 $3.36